Pancrelipase clinical trials
Also written Creon, Zenpep, Pancreatin and SA-001.
How each study uses Pancrelipase is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Pancrelipase studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 9 Dec 1996 · COTAZYM · BLA 020580 (FDA, Drugs@FDA; in a combination)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
44 studies that test it; most in 2008 (6)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2000 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 6 |
| 2009 | 1 |
| 2010 | 3 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 26 · Other 18
Forest Laboratories (6) · Abbott (5) · AbbVie (4) · Abbott Products (3) · Digestive Care, Inc. (3) · Samjin Pharmaceutical Co., Ltd. (2) · Solvay Pharmaceuticals (2) · Memorial Sloan Kettering Cancer Center (1)
Often tested with
Tested in the same studies.
Bifidobacterium longum subsp. infantis (1) · Nitazoxanide (1) · Ensure Plus (1) · Bicarbonates (1) · Esomeprazole (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3
Studies that test Pancrelipase.
- Nov 2026Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)Phase 1/2 · Memorial Sloan Kettering Cancer Center
- Jan 2027Pancrelipase With Nutritional Supplement in Patients at Risk of Malnutrition (EFFORT-ENZO)Not applicable · Philipp Schuetz
- Sep 2027Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic InsufficiencyPhase 4 · Ohio State University
Studies
Open first, then newest update. How each study uses Pancrelipase is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 44
- Pancreatin Added to Standard Antihyperglycemic Therapy in Patients With Type 2 DiabetesRecruitingPhase 4Silesian Centre for Heart DiseasesNCT07852988Written as PancreatinHow we know
- Pancrelipase With Nutritional Supplement in Patients at Risk of Malnutrition (EFFORT-ENZO)RecruitingNot applicablePhilipp SchuetzNCT06826105Written as ZenpepHow we know
- Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic InsufficiencyRecruitingPhase 4Ohio State UniversityNCT06477159Written as Pancrelipase CapsulesHow we know
- Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)Active, not recruitingPhase 1/2Memorial Sloan Kettering Cancer CenterNCT05642962Written as PertzyeHow we know
- Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic InsufficiencyActive, not recruitingPhase 2Andrew Hendifar, MDNCT04098237Written as PancrelipaseHow we know
- Effect of Enzyme Therapy on Protein Metabolism in Chronic PancreatitisCompletedNot applicableInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'EnvironnementNCT01154608Written as CreonHow we know
- Pancreatic Enzyme Replacement and Glucose Regulation in Type 1 DiabetesCompletedEarly Phase 1Vanderbilt University Medical CenterNCT05266963Written as CREONHow we know
- Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or Chronic Pancreatitis Treated With CreonCompletedPhase 4AbbVieNCT05069597Written as CREONHow we know
- A Study to Compare US Marketed Creon Manufactured With a Modernized Process at an Alternate Manufacturing Site and Manufactured With the Approved Manufacturing Process at an Alternate Active Pharmaceutical Ingredient Site, in Participants With Exocrine Pancreatic Insufficiency Due to Cystic FibrosisCompletedPhase 4AbbVieNCT03924947Written as PancrelipaseHow we know
- A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)TerminatedPhase 4AbbVieNCT03859869Written as PancrelipaseHow we know
- Clinical Study to Investigate the Efficacy of Orally Administered SA001 in Patients With Primary Sjögren's SyndromeCompletedPhase 2Samjin Pharmaceutical Co., Ltd.NCT05269810Written as SA001 Low doseHow we know
- Clinical Study to Investigate the Efficacy and Safety of Orally Administered SA001 in Patients With Dry Eye Syndrome.CompletedPhase 2Samjin Pharmaceutical Co., Ltd.NCT03723798Written as SA001 Low doseHow we know
- Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic CancerWithdrawnPhase 4AbbVieNCT04315311Written as CREONHow we know
- PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic CancerTerminatedPhase 1/2Massimo Raimondo, M.D.NCT02985801Written as PancrelipaseHow we know
- Improving Treatment of Nontuberculous Mycobacterial Infection in Cystic FibrosisCompletedNot applicableUniversity of Colorado, DenverNCT02372383Written as PancrelipaseHow we know
- Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic AdenocarcinomaTerminatedPhase 2Dana-Farber Cancer InstituteNCT03469258Written as PancrelipaseHow we know
- Creon Use in Coeliac Patients With Low Faecal Pancreatic ElastaseTerminatedPhase 4Sheffield Teaching Hospitals NHS Foundation TrustNCT01865695Written as CreonHow we know
- Fat Malabsorption in Chronic PancreatitisCompletedPhase 2Children's Hospital of PhiladelphiaNCT02849704Written as Creon36™How we know
- Irritable Bowel Syndrome Evaluation and Treatment in Primary CareCompletedPhase 4American Academy of Family PhysiciansNCT01641341Written as PancrelipaseHow we know
- Trial of Pancreatic Enzyme Supplements (Pancrelipase) for Treating Pain in Patients With Chronic PancreatitisWithdrawnPhase 2Dartmouth-Hitchcock Medical CenterNCT02706236Written as PancrelipaseHow we know
See all 44 studies that test Pancrelipase →
Given beside what is tested · 1 — Pancrelipase is usual care or a partner of the new treatment
As the comparator · 4 — what is tested is compared with Pancrelipase
- Phase 2 Study to Assess the Safety and Efficacy of ANG003RecruitingPhase 2Anagram Therapeutics, Inc.NCT07450547Written as CreonHow we know
- CREON for the Treatment of Post-RYGB HypoglycemiaTerminatedPhase 1East Carolina UniversityNCT02733848Written as CreonHow we know
- A Study of EUR-1066 in Subjects With Chronic Pancreatitis, Exocrine Pancreatic Insufficiency and Chronic Abdominal PainTerminatedPhase 1Forest LaboratoriesNCT01159119Written as ZenpepHow we know
- Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic InsufficiencyStatus unknownPhase 2/3Azidus BrasilNCT01012908Written as CreonHow we know
Codes
What other systems call Pancrelipase · ClinicalTrials.gg INT008771
- MeSH (NLM) D020799PancrelipaseConfirmed ClinicalTrials.gov, Wikidata
- UNII (FDA) FQ3DRG0N5KPANCRELIPASEConfirmed FDA, Wikidata
- RxNorm 235379Confirmed FDA, Wikidata
- Wikidata Q7130425pancrelipaseConfirmed FDA, Wikidata
- NCI Thesaurus C29345PancrelipaseOne source FDA
- DrugBank DB00085One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D020799 | Pancrelipase | Confirmed ClinicalTrials.gov, Wikidata |
| UNII (FDA) | FQ3DRG0N5K | PANCRELIPASE | Confirmed FDA, Wikidata |
| RxNorm | 235379 | — | Confirmed FDA, Wikidata |
| Wikidata | Q7130425 | pancrelipase | Confirmed FDA, Wikidata |
| NCI Thesaurus | C29345 | Pancrelipase | One source FDA |
| DrugBank | DB00085 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.